Diagnostic healthcare products manufacturer Quidel has confirmed that its antigen tests have the capability to detect the new emerging Covid-19 variants such as Omicron.
The company’s Sofia SARS Antigen FIA and QuickVue At-Home OTC COVID-19 Test were found to detect the Omicron variant in the recent testing of live samples from South Africa.
The QuickVue test is designed to detect the nucleocapsid protein antigen from SARS-CoV-2 in people with or without symptoms.
